Introduction {#sec1-1}
============

Hyperlactatemia are common findings in critically ill patients and have significant prognostic implications. Lactate levels are frequently cited as an indicator of inadequate tissue perfusion or oxygenation, particularly in sepsis.\[[@ref1]\] The severity and duration of lactic acidosis in critically ill patients correlate with overall oxygen debt, potential organ dysfunction, and mortality.\[[@ref2]\]

Single lactate level, particularly those measured on Intensive Care Unit (ICU) entry or arrival at the emergency department (ED), has been thought to be a strong predictor of subsequent organ dysfunction and mortality. Trzeciak *et al*. showed that an initial lactate level of more than 4 mmol/L was associated with substantial increases in the probability of acute-phase death.\[[@ref3]\] The predictive value of initial lactate has been confirmed in several large cohort or database studies.\[[@ref4][@ref5][@ref6]\] However, a single measurement of lactate is a static variable and can only serve as a risk-stratification biomarker. Serial measurements or lactate clearance (LC) over time may be better prognosticators of organ failure and mortality than a single lactate measurement.\[[@ref7][@ref8][@ref9][@ref10][@ref11][@ref12]\]

Nguyen *et al*. and Jansen *et al*. have suggested the role of LC as a marker of mortality prediction in adults.\[[@ref13][@ref14]\] LC is closely associated with capillary perfusion independent of hemodynamic variables, and it is thought to be a good biomarker of microcirculation\[[@ref13]\] representative of impaired diffusion of oxygen capacity. Serial lactate measurements may also aid in assessing the adequacy of resuscitation.\[[@ref13]\] Various studies have shown that persistent hyperlactatemia beyond 24--48 h was associated with mortality, poor neurological outcome, and organ failure.\[[@ref13][@ref14][@ref15][@ref16]\]

A study by Nguyen *et al*. comparing survivors with nonsurvivors had an LC of 38.1% ± 34.6% versus 12.0% ± 51.6%, respectively (*P* = 0.005). There was an approximately 11% decrease likelihood of mortality for each 10% increase in LC.\[[@ref13]\] A recently completed multicenter, randomized, controlled trial demonstrated that LC of 10% or more is noninferior to the use of continuous ScvO~2~ monitoring in determining the adequacy of resuscitation and oxygen supply/demand relationship during the early resuscitation of severe sepsis and septic shock.\[[@ref17]\] Taken together, these data demonstrate the utility of LC not only as a prognostic marker in sepsis but also as a valuable endpoint of early resuscitation, it can be used as a tool to predict the outcome.

One pediatric study looked at LC at 24 h for mortality prediction is published. The study suggested that persistent hyperlactatemia \>2 mM after 24 h was associated with 93% mortality as compared to 30% in normalized lactate level.\[[@ref8]\]

Pilot study to look at LC for mortality prediction in children showed LC \<30% at 6 h was significantly associated with mortality.\[[@ref18]\] Hence, we planned to validate this finding of LC at 6 h for mortality prediction.

 {#sec2-1}

### Aims and objectives {#sec3-1}

To validate the LC at 6 h for prediction of mortality in Pediatric ICU (PICU)-admitted patients and its comparison with expected mortality prediction by pediatric index of mortality 2 (PIM 2) score.

Materials and Methods {#sec1-2}
=====================

It was a prospective, observational study in a tertiary care PICU, New Delhi, between May 2014 and June 2015. Institutional Ethical Committee approval was obtained prior to undertaking the study. Informed and written consents were obtained from the parents of all participating children. Inclusion criteria: Children of \>1 month and \<13 years of age, who were admitted in PICU during study period.

Children with do not resuscitate orders, inborn errors of metabolism, trauma patients, and those who refused consent were excluded from the study.
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### Sample size {#sec3-2}

By taking confidence level of 95% and confidence interval (CI) of 10%, the sample size required was 138 children.

### Methodology {#sec3-3}

A three-step approach was used.

**Step 1**

All children admitted in PICU not meeting any of the exclusion criteria were included in the study after taking written and informed consents.

**Step 2**

All enrolled patients underwent following:

Detailed history and physical examination were recorded. All preliminary investigations for detecting organ failure including those necessary to calculate PIM 2 score were done at admissionBlood gas analysis (including lactate) was measured first at admission (0) and then after 6 h of admission using a "Radiometer Copenhagen ABL 555" blood gas analyzer.

**Step 3**

All patients were managed as per our unit standard clinical practice. PIM 2 score was measured, and PIM 2 risk of mortality was calculated using a web-based calculator ([www.sfar.org/scores2/pim22.html](www.sfar.org/scores2/pim22.html)) for calculation of predicted mortality rate. The system computes the predicted mortality rate based on standard methods using logistic regression equation.

LC (%) is defined using the following formula: lactate at ED presentation (h 0) minus lactate at h 6, divided by lactate at ED presentation, then multiplied by 100. A positive value denotes a decrease or clearance of lactate whereas a negative value denotes an increase in lactate after 6 h of ED intervention.\[[@ref18]\]
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Final diagnosis and outcome were recorded.

### Statistical analysis {#sec3-4}

We compared the two groups (clearance vs. nonclearance) for in-hospital mortality. Expected mortality by PIM 2 score at admission was compared with LC versus nonclearance group by Mann--Whitney U-test.

Quantitative data were presented as mean ± standard deviation (SD). The values results were not normally distributed and thus were analyzed nonparametrically. Survivors and nonsurvivors were compared by the Mann--Whitney U-test for continuous variables and by Fisher\'s exact test for categorical variables. Pair-wise comparisons were made using Wilcoxon\'s signed-rank test. A *P* \< 0.05 was taken as statistically significant. Sensitivity, specificity, positive predictive value, and negative predictive value of LC for mortality were calculated.

SPSS version 17.0, USA was used for statistical analysis.

Observations and Results {#sec1-3}
========================

One hundred and forty children admitted to PICU who fulfilled inclusion criteria were included in this study. The mean age of the study population (*n* = 140) was 33.42 months. Of the 140 children, 98 (70%) were males and 23 (16.4%) patients died. Mean lactate (mmol/L) at admission was low in those who survived in comparison to nonsurvivors (3.117 vs. 5.017) (*P* 0.009).

Wilcoxon signed-rank test showed statistically significant difference in lactate levels at 0 and 6 h of admission in those who survived (mean lactate at 0 h: 3.117; SD: 2.840 and at 6 h: 1.968; SD: 1.821, *P* = 0.000) compared to the nonsurvived group (mean at 0 h: 5.017; SD: 3.615) at 6 h (mean: 5.726; SD: 3.3724%, *P* = 0.070) \[[Table 1](#T1){ref-type="table"}\]. The area under receiver operating characteristic (ROC) curve for mortality prediction was 0.823 (95% CI: 0.715--0.931) \[*P* = 0.000, [Graph 1](#F1){ref-type="fig"}\]. Based on ROC curve, a cut-off value of 16.435% LC at 6 h was associated with mortality. An optimal LC cut-off was defined as that LC with the maximum sum of sensitivity plus specificity for predicting in-hospital mortality.

###### 

Mean lactate (mmol/L) levels in two groups (died vs. survived) group
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![Receiver operating characteristic curve for lactate clearance at 6 h for mortality prediction. Area under curve 0.823 (95% confidence interval: 0.715--0.931)](IJCCM-20-570-g003){#F1}

Low LC group (≤16.435%) had 39.6% mortality compared to 4.3% in high clearance group (\>16.435%) (*P* = 0.000). Measure of agreement by kappa statistics between LC \<16.435% at 6 h and mortality was 0.402. LC ≤16.435% at 6 h for mortality prediction had sensitivity of 82.6%, specificity 75.2%, positive predictive value of 39.6%, and negative predictive value of 95.7% \[[Table 2](#T2){ref-type="table"}\].

###### 

Outcome based on cut-off level of lactate clearance (16.435%)
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PIM 2 score cut-off of 12.3% was associated with mortality. Above this cutoff value, high mortality was observed (42.2%) than in those below this cut-off (4.2%) (*P* = 0.000).

In delayed/non-LC group, the mean PIM 2 score was 25.2583% (SD: 27.94219) whereas in clearance group was 10.9522% (SD: 16.92542).

Comparison of expected mortality by PIM 2 score at admission in LC versus non-LC group by Mann--Whitney U-test was significant \[*P* = 0.004, [Table 3](#T3){ref-type="table"}\].

###### 

Comparing expected mortality by pediatric index of mortality 2 score at admission in lactate clearance versus nonlactate clearance groups

![](IJCCM-20-570-g005)

Discussion {#sec1-4}
==========

The predictive value of initial lactate has been confirmed in several large cohort or database studies.\[[@ref4][@ref5][@ref6][@ref7]\] However, a single measurement of lactate is a static variable and can only serve as a risk-stratification biomarker. To make it more clinically useful, trend of "lactate clearance," during treatment at 6 h of hospital stay, was explored and its association with mortality was found.

Various studies have shown high lactate levels in serial measurements and prolonged time to normalize lactate and predicted a higher mortality rate.\[[@ref7][@ref8][@ref9][@ref10][@ref11][@ref13][@ref14][@ref15][@ref19]\] There are very few studies which look at the outcome of LC at 6 h of admission.\[[@ref13][@ref18][@ref20][@ref21]\] We observed higher mortality in non-LC group (39.6% vs. 4.3%; *P* = 0.000) which is similar to the study by Arnold *et al*.\[[@ref17]\] (60% vs. 19% at LC cut-off of 10% at 6 h of hospital stay, *P* \< 0.001) and also similar to the study by Nguyen *et al*.\[[@ref13]\] who observed that clearance \<10% in 6 h was associated with a higher mortality (*P* = 0.007). The cut-off value of LC to predict mortality at 6 h by Nguyen *et al*. was 10%, while in our study it is higher (16.435%), probably because they studied LC only in cases with severe sepsis and septic shock, while in our study we considered cases irrespective of underlying etiology.

Hatheril *et al*.\[[@ref8]\] showed that persistent hyperlactatemia \>2 mM after 24 h was associated with 93% mortality as compared to 30% in those children whose lactate level had normalized, (likelihood ratio of 7, sensitivity 78%, and specificity 89%). The area under the ROC curve for lactate \>2 mM at 24 h after admission was 0.86. Although area under ROC curve of 0.823 and sensitivity of 82.6% in our study is comparable to their study, specificity of 75.2% in ours is low compared to their study because they did not look at LC but they looked at persistent hyperlactatemia \>2 mM after 24 h for the association of mortality.

Munde *et al*.\[[@ref18]\] looked at LC at 6 h and observed that mortality was high in delayed or non-LC group than clearance group (75% vs. 25% with a *P* = 0.000). In their study, LC of \<30% at 6 h for prediction of mortality in PICU-admitted children had a sensitivity of 75% and specificity 97%. The area under ROC curve was 0.977 (95% CI: 0.943--1.012) for mortality prediction. Although their sensitivity is comparable to our study, specificity in our study is less, probably because they took a very high cut-off of LC \<30% for mortality prediction. The area under ROC curve in their study is high because of high cut-off of LC (\<30%) and high mortality (90%) among delayed or non-LC compared to our study.

In delayed/non-LC group, mean PIM 2 score was 25.2583% and in clearance group was 10.9522% (SD: 16.92542%, *P* = 0.004). PIM 2 score of more than 12.3% (cut = off value) for expected mortality and an LC less than cut-off value (16.435%) were comparable.

The limitations of our study is that it includes only patients admitted to the PICU and excludes those admitted in step down units, trauma cases and those who are non critically ill.

Conclusion {#sec1-5}
==========

We found an lactate clearance cut off cut-off of around 16% at 6 h in critically ill patients is comparable to PIM 2 score for mortality prediction.
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